GSK Consumer Healthcare Ltd

Size: px
Start display at page:

Download "GSK Consumer Healthcare Ltd"

Transcription

1 GICS Industry : Food Products l Sub Industry : Packaged foods & meats l Website : GSK Consumer Healthcare Ltd Key Stock Indicators NSE Ticker : GSKCONS Bloomberg Ticker : SKB:IN Face value / Share: 1. Div. Yield (%):.9 CMP (as on 28 Jan 211 Rs/Share) weekrange up to 28 Jan 211 (Rs)(H/L): 239.1/ Market Cap as on 28 Jan 211 (Rs Mn): 8,14 Enterprise Value as on 28 Jan 211 (Rs Mn): 76,96 Shares outstanding (mn): 42.1 Free Float (%): 6.8 Average daily volumes (12 months) : 17,98 Beta (2 year) :.6 GlaxoSmithKline Consumer Healthcare (GSKCH) is an associate of GlaxoSmithKline Plc (UK). The parent company was formed in 2, following the merger between GlaxoWellcome and SmithKline Beecham. GSKCH s product portfolio consists of nutritional products such as Horlicks, Boost and Maltova, and also drugs such as rubefacients (Iodex) and gastrointestinal/ analgesics such as Crocin and Eno. KEY HIGHLIGHTS Product portfolio has strong brands GSKCH s product portfolio consists of nutritional brands such as Horlicks, Boost and Maltova, while it has rubefacients like Iodex and gastrointestinal/ analgesics brands like Crocin and Eno. Horlicks is a well-know brand in the white segment of the health food drinks industry and contributes significantly to its market share there. Extension of product line The company s R&D function has fostered the development of new products through innovation. Products introduced in 29 include Glaxo Nutrition's ActiGrow, Horlicks Nutribar, Junior Horlicks, biscuits, Asha from Horlicks, Horlicks Cornflake Crunchies Biscuits, Foodles from Horlicks and Horlicks Proheight. GSKCH is a part of GlaxoSmithKline Plc of the UK, which has a 27% market share in the global pharmaceutical market. Exports drive growth The Company exports products to Bangladesh, Myanmar, Sri Lanka, Malaysia, to the Middle East and other markets. Efforts are also being made to target markets in Southeast Asia. Exports registered a CAGR of 36.17% from CY6 to CY9. Exports contributed ~8% of the total revenue CY9. Key Financial Indicators Dec-7 Dec-8 Dec-9 Revenue (Rs mn) 13, , ,8.7 EBITDA margins (%) PAT (Rs mn) 1, , ,327.8 PAT margins(%) Gearing (x) EPS (Rs/share) PE (x) P/BV (x) RoCE (%) RoE (%) EV/EBITDA (x) n.m. : Not meaningful 2.6 Shareholding (As on September 3, 21) FII 11% DII 19% Others 27% KEY RISKS Expiry of drug patents Drug price control order (DPCO) imposed by Government of India Stock Performances vis-à-vis market Indexed price chart Promoter 43% Returns (%) YTD 1-m 3-m 12-m GSKCONS NIFTY Note: 1) YTD returns are since Jan 4, 21 to Jan 28, ) 1-m, 3-m and 12-m returns are up to Jan 28, 211. (index) Jan-1 Feb-1 Mar-1 Apr-1 May-1 Jun-1 Jul-1 Aug-1 Sep-1 Oct-1 Nov-1 Dec-1 (') Volumes (RHS) GSKCONS NIFTY CRISIL COMPANY REPORT 1

2 BACKGROUND GSKCH is the Indian associate of GlaxoSmithKline Plc (UK). Its product portfolio consists of nutritional products such as Horlicks, Boost and Maltova, while on the pharma side, it has rubefacients like Iodex and gastrointestinal/ analgesics like Crocin and Eno. The company has manufacturing facilities at Nabha in Punjab, Rajahmundry in Andhra Pradesh and Sonepat in Haryana. It has an established distribution network in India. GSKCH exports to Bangladesh, Myanmar, Sri Lanka, Malaysia, and the Middle East. Exports contributed ~8% of total revenue for CY9. The company s R&D division has helped develop new products, including 29 s launches such as Glaxo Nutrition's ActiGrow, Horlicks Nutribar etc. COMPETITIVE POSITION Peer Comparison GlaxoSmithKline Consumer Healthcare Ltd Nestle India Ltd REI Agro Ltd annia Industries Ltd Dec-9 Dec-9 Mar-1 Mar-1 Revenue (Rs mn) 19,8.7 1,23. 36, ,871.9 EBITDA margins (% PAT (Rs mn) 2, ,. 1,71.7 1,33.2 PAT margins(%) Gearing (x) EPS (Rs/share) PE (x) P/BV (x) RoCE (%) RoE (%) EV/EBITDA (x) n.m: Not meaningful FINANCIAL PROFILE Top-line and PAT grow in FY1, operating margin stays flat The company s top-line grew 22.8% CAGR from CY7 to CY9 on the back of price increases and volume growth. EBITDA margin remained flat as costs rose in proportion to increase in revenues. PAT increased by 23.6 % in CY9 to Rs 2.3 bn, helped by reduction in operating expenses as a result of efficient operations. Key Financial Indicators Units Dec-7 Dec-8 Dec-9 Revenue Rs million 13, , ,8.7 EBITDA margins PAT Rs million 1, , ,327.8 PAT margins Revenue growth EBITDA growth PAT growth Gearing Times... RoCE RoE CRISIL COMPANY REPORT 2

3 INDUSTRY PROFILE Pharmaceuticals Over the past five years, the Indian pharmaceutical industry grew at a CAGR of about per cent and reached a market size of about $21.4 billion in The industry is dominated by exports which are estimated to have contributed about 6 per cent to the industry in The strong growth in the Indian pharmaceuticals industry has been primarily driven by exports of formulations and bulk drugs while the domestic formulations market has maintained its steady growth. Between 24- and 29-1, formulation exports have surged at a CAGR of -27 per cent owing to the opening-up of a huge generic opportunity in regulated market while demand from the semi-regulated market remained robust. In the domestic market, the emergence of lifestyle segments such as anti-diabetic, cardiovascular and gastrointestinal have been chief growth (12-14 per cent) drivers over the last 4- years. Bulk drug exports have grown at a compounded rate of 34-3 per cent over the last five years to an estimated $7. billion in Indian companies have the advantage of lower costs and well-developed process chemistry skills (employee and manufacturing costs) as compared to companies in US and Europe. Indian players are increasingly focusing on exports to generic players and innovators in regulated markets. Branded Foods The branded foods industry includes units manufacturing bakery products, dairy and milk products, confectioneries and ready-to-eat products. While India ranks among the largest food producers in the world, its share in the processed food industry is miniscule, reflecting the low penetration levels and inadequate supply chain infrastructure. India, however, has an abundant supply of the raw materials as it is one of the world`s largest producers of milk, food grains, fruits, vegetables, spices, sugar and oilseeds. Demand growth in the branded foods industry depends on the ability of manufacturers to offer a wide range of products that meet regional tastes at competitive prices. Increase in the level of penetration, especially in urban areas, will depend primarily on the growth in income levels and the number of working women. Government policies do not have a large bearing on the branded foods industry. Policy changes have, however, largely been supportive to the growth of the sector. The industry was accorded priority status for bank lending in Organised players in the branded foods industry face stiff competition from regional brands. Imported food products are costlier than local equivalents and are, therefore, not competitive in the domestic market. CRISIL COMPANY REPORT 3

4 ANNUAL RESULTS Income Statement Balance sheet (Rs million ) Dec-7 Dec-8 Dec-9 (Rs million ) Dec-7 Dec-8 Dec-9 Net Sales 12,74. 1, ,248.7 Equity share capital Operating Income 13, , ,8.7 Reserves and surplus,947. 7, ,626.6 Tangible net worth 6,367. 7,8.9 9,47.1 EBITDA 2, ,91.2 3,741.3 Deferred tax liablity: asset EBITDA Margin Long-term debt... Short-term-debt... Depreciation Total debt... Interest Current liabilities 2,181. 2,.2 3,89.6 Other Income Total provisions ,294.7 Total liabilities 9,27. 1, ,41.3 PBT 2,41.4 2,84.9 3,64.7 Gross block 4,72.6 4,73. 4,92.6 PAT 1, , ,327.8 Net fixed assets 2, ,21.7 2,318.8 Investments 2, PAT Margin Current assets 3, , ,722. Receivables No. of shares (Mn No.) Inventories 1, , ,66.3 Cash ,79.8 8,198. Earnings per share (EPS) Total assets 9,27. 1, ,41.3 Cash flow Ratio (Rs million ) Dec-7 Dec-8 Dec-9 Dec-7 Dec-8 Dec-9 Pre-tax profit 2, ,9.9 3,611.9 Revenue growth (%) Total tax paid ,64. -1,412.9 EBITDA growth(%) Depreciation PAT growth(%) Change in working capital ,279. EBITDA margins(%) Cash flow from operating activities 2,13.6 1, ,898.2 Tax rate (%) Capital Expenditure PAT margins (%) Investments and others , Dividend payout (%) Cash flow from investing activities -1,7.9 2, Return on Equity (%) Equity raised/(repaid)... Return on capital employed (%) Debt raised/(repaid)... Dividend (incl. tax) Gearing (x)... Others (incl extraordinaries) Interest coverage (x) Debt/EBITDA (x)... Cash flow from financing activities Change in cash position 47. 3, ,488.1 Asset turnover (x) Opening cash ,79.8 Current ratio (x) Closing cash ,79.8 8,198. Gross current assets (days) QUARTERLY RESULTS Profit and loss account (Rs million) Sep-1 % of Rev Sep-9 % of Rev Jun-1 % of Rev Sep-1 % of Rev Sep-9 % of Rev No of Months Revenue 6, , , , , EBITDA 1, , , , Interest Depreciation PBT 1, , , , PAT , , CRISIL COMPANY REPORT 4

5 FOCUS CHARTS & TABLES Rs mn 8, 7, 6,, 4, 3, 2, 1, Dec-7 Mar-8 Sales Quarterly sales & y-o-y growth Jun-8 Sep-8 Dec-8 Mar-9 Jun-9 Sep-9 Dec-9 Mar-1 Jun-1 Sep-1 Sales growth y-o-y (RHS) Rs mn 1,2 1, Dec-7 Mar-8 Quarterly PAT & y-o-y growth Jun-8 Net Profit Sep-8 Dec-8 Mar-9 Jun-9 Sep-9 Dec-9 Mar-1 Jun-1 Sep-1 Net profit growth y-o-y (RHS) Rs/share EPS 3 Movement in operating and net margins Dec-7 Mar-8 Jun-8 Sep-8 Dec-8 Mar-9 Jun-9 Sep-9 Dec-9 Mar-1 Jun-1 Sep-1 Dec-7 Mar-8 Jun-8 OPM Sep-8 Dec-8 Mar-9 Jun-9 Sep-9 Dec-9 Mar-1 NPM Jun-1 Sep-1 Shareholding Pattern () Board of Directors Mar 21 Jun 21 Sep 21 Dec 21 Director Name Promoter Simon James Scarff (Mr.) FII DII Zubair Ahmed (Mr.) Others Subodh K. Bhargava (Mr.) Mukesh Hari Butani (Mr.) Naresh Dayal (Mr.) Designation Non-Executive Chairman, Promoter- Director Managing Director P. Dwarakanath (Mr.) Praveen Kumar Gupta (Mr.) Director Kunal Kashyap (Mr.) Ramakris hnan Subramanian (Mr.) Director Additional Disclosure This report has been sponsored by NSE - Investor Protection Fund Trust (NSEIPFT). Disclaimer This report is based on data publicly available or from sources considered reliable. CRISIL Ltd. (CRISIL) does not represent that it is accurate or complete and hence, it should not be relied upon as such. The data / report is subject to change without any prior notice. Opinions expressed herein are our current opinions as on the date of this report. Nothing in this report constitutes investment, legal, accounting or tax advice or any solicitation, whatsoever. The subscriber / user assume the entire risk of any use made of this data / report. CRISIL especially states that, it has no financial liability whatsoever, to the subscribers / users of this report. This report is for the personal information only of the authorised recipient in India only. This report should not be reproduced or redistributed or communicated directly or indirectly in any form to any other person especially outside India or published or copied in whole or in part, for any purpose. CRISIL is not responsible for any errors and especially states that it has no financial liability whatsoever to the subscribers / users / transmitters / distributors of this report. For information please contact 'Client Servicing' at , or via clientservicing@crisil.com. CRISIL COMPANY REPORT

Hindustan Oil Exploration Co. Ltd

Hindustan Oil Exploration Co. Ltd GICS Industry : Oil, Gas & Consumable Fuels l Sub Industry : Oil & Gas Exploration & Production l Website : www.hoec.com Hindustan Oil Exploration Co. Ltd Key Stock Indicators NSE Ticker : HINDOILEXP Bloomberg

More information

Oil India Ltd KEY HIGHLIGHTS. Shareholding (As on September 30, 2010) KEY RISKS. Stock Performances vis-à-vis market. Indexed price chart

Oil India Ltd KEY HIGHLIGHTS. Shareholding (As on September 30, 2010) KEY RISKS. Stock Performances vis-à-vis market. Indexed price chart GICS Industry : Oil, Gas & Consumable Fuels l Sub Industry : Oil & Gas Exploration & Production l Website : www.oil-india.com Oil India Ltd Key Stock Indicators NSE Ticker : OIL Bloomberg Ticker : OINL:IN

More information

Orient Paper & Industries Ltd

Orient Paper & Industries Ltd GICS Industry : Construction Materials l Sub Industry : Construction Materials l Website : www.orientpaperindia.com Orient Paper & Industries Ltd Key Stock Indicators NSE Ticker : ORIENTPPR Bloomberg Ticker

More information

Uco Bank. GICS Industry : Commercial Banks Sub Industry : Diversified Banks Website : Key Stock Indicators

Uco Bank. GICS Industry : Commercial Banks Sub Industry : Diversified Banks Website :  Key Stock Indicators GICS Industry : Commercial Banks Sub Industry : Diversified Banks Website : www.ucobank.com Uco Bank Key Stock Indicators NSE Ticker : UCOBANK CMP as on 11 May 2011 Rs/share : 99.9 Shares outstanding (mn)

More information

GSK Consumer Healthcare Ltd

GSK Consumer Healthcare Ltd Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16. Volume No.. I Issue No. 67 GSK Consumer Healthcare Ltd Apr 19 th, 2016 BSE Code: 500676 NSE Code: GSKCONS Reuters

More information

The Jeypore Sugar Company Ltd

The Jeypore Sugar Company Ltd The Jeypore Sugar Company Ltd Q3FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses

More information

Religare Investment Call

Religare Investment Call v-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 v-18 Q2FY19 Result Update Q2FY19 Result Update BUY CMP (Rs) 5,813 Target Price (Rs) 6,519 Potential Upside 12.1% Sensex

More information

Punjab Chemicals and Crop Protection Ltd

Punjab Chemicals and Crop Protection Ltd Q3FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis

More information

Company Overview. Financial Performance

Company Overview. Financial Performance Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 Jan/16 CMP: 32.30 February 11, 2016 Stock Details BSE code 526558 BSE ID JAMEHOT Face value ( ) 10 No of shares (m) 8.0 52 week

More information

Company Overview. Financial Performance

Company Overview. Financial Performance Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 Jan/16 Feb/16 Mar/16 Monarch Networth Capital Limited CMP: 26.00 March 23, 2016 Stock Details BSE code 511551 BSE ID MONARCH Face value (

More information

The Jeypore Sugar Company Ltd

The Jeypore Sugar Company Ltd Q1FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)

More information

Company Overview. Financial Performance

Company Overview. Financial Performance Jan/15 Feb/15 Mar/ Apr/15 May/ Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/ Dec/15 Parnax Lab Limited CMP: 53.90 January 08, 2016 Stock Details BSE code 506128 BSE ID PARNAXLAB Face value ( ) 10 No of shares

More information

Aarti Industries Ltd KEY HIGHLIGHTS. Shareholding (As on December 31, 2010) KEY RISKS. Indexed price chart. Stock Performances vis-à-vis market

Aarti Industries Ltd KEY HIGHLIGHTS. Shareholding (As on December 31, 2010) KEY RISKS. Indexed price chart. Stock Performances vis-à-vis market GICS Industry: Chemicals l Sub Industry: Specialty Chemicals l Website : www.aartigroup.com Aarti Industries Ltd Key Stock Indicators NSE Ticker: AARTIIND Bloomberg Ticker: ARTO: IN Face value / Share:

More information

Hitech Plast Ltd. Q4FY11 First Cut. Enhancing investment decisions. CRISIL Limited. All Rights Reserved.

Hitech Plast Ltd. Q4FY11 First Cut. Enhancing investment decisions. CRISIL Limited. All Rights Reserved. Q4FY11 First Cut Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis

More information

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart 1QCY2016 Result Update Pharmaceutical May 5, 2016 Sanofi India Performance Highlights Y/E Dec. (` cr) 1QCY2016 4QCY2015 % chg (qoq) 1QCY2015 % chg (yoy) Net sales 506 522 (3.1) 460 10.1 Other income 64

More information

NATCO PHARMA LTD. Result Update (PARENT BASIS): Q1 FY16

NATCO PHARMA LTD. Result Update (PARENT BASIS): Q1 FY16 ISIN: INE987B01018 OCTOBER 15 th, 2015 STOCK DETAILS Sector NATCO PHARMA LTD. Result Update (PARENT BASIS): Q1 FY16 BSE Code 524816 Face Value 10.00 Pharmaceuticals 52wk. High / Low (Rs.) 2709.00/1245.40

More information

Company Overview. Industry Overview. Financial Performance

Company Overview. Industry Overview. Financial Performance Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 Jan/16 Trade Wings Limited CMP: 105.00 January 29, 2016 Stock Details BSE code 509953 BSE ID TRADWIN Face value ( ) 10 No of

More information

Institutional Equities

Institutional Equities 3QFY15 Result Update Institutional Equities GlaxoSmithKline Consumer Healthcare Reuters: GLSM.BO; Bloomberg: SKB IN 4 February 2015 Price Hike Leads To Sales Growth Glaxo SmithKline Consumer Healthcare

More information

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials 1QCY212 Result Update Tyres June 6, 212 Goodyear India Performance Highlights Y/E December (` cr) 1QCY212 1QCY211 % chg (yoy) 4QCY211 % chg (qoq) Net sales 331 336 (1.6) 395 (16.2) EBITDA 2 24 (18.6) 34

More information

GlaxoSmithKline Consumer. Healthcare Ltd Result Update: Q3 CY 11 SYNOPSIS. C.M.P: Rs Target Price: Rs Date: Dec 05 th 2011 BUY

GlaxoSmithKline Consumer. Healthcare Ltd Result Update: Q3 CY 11 SYNOPSIS. C.M.P: Rs Target Price: Rs Date: Dec 05 th 2011 BUY GlaxoSmithKline Consumer Healthcare Ltd Result Update: Q3 CY 11 C.M.P: Rs. 2522.00 Target Price: Rs. 2850.00 Date: Dec 05 th 2011 BUY Stock Data: Sector: Food Processing Face Value Rs. 10.00 52 wk. High/Low

More information

Amber Enterprises India Ltd

Amber Enterprises India Ltd 3QFY2019 Result Update Consumer Durable February 16, 2019 Amber Enterprises India Ltd Performance Update (` cr) 3QFY19 3QFY18 % yoy 2QFY19 % qoq Revenue 388.8 338.4 14.9 226.3 71.8 EBITDA 22.1 24.1 (8.2)

More information

Company Overview. Financial Performance

Company Overview. Financial Performance Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 KMC Speciality Hospitals India Ltd CMP: 7.61 January 21, 2015 Stock Details BSE code 524520 BSE ID KMCSHIL Face value

More information

Kandagiri Spinning Mills Ltd

Kandagiri Spinning Mills Ltd Q1FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)

More information

Company Overview. Industry Overview. Financial Performance

Company Overview. Industry Overview. Financial Performance Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 CMP: 27.80 January 20, 2016 Stock Details BSE code 534623 BSE ID JUPITERIN Face value ( ) 10 No of shares (m) 10 52 week

More information

Company Overview. Financial Performance

Company Overview. Financial Performance Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Superior Industrial Enterprises Limited CMP: 19.6 December 24, 215 Stock Details BSE code 519234 BSE ID SIEL Face value

More information

Company Overview. Financial Performance

Company Overview. Financial Performance Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Nimbus Projects Limited CMP: 34. December 4, 15 Stock Details BSE code 511714 BSE ID NIMBSPROJ Face value ( ) 1 No of

More information

Plastiblends India Ltd

Plastiblends India Ltd Q3FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis

More information

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart. Ltd. Creating value through paper Limited (RPL) manufactures writing paper, printing paper and Kraft paper. The company's white writing and printing paper is used in making notebooks and writing material,

More information

eclerx Services Ltd Q3FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved.

eclerx Services Ltd Q3FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Q3FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)

More information

BUY. IFB AGRO INDUSTRIES LTD Result Update (PARENT BASIS): Q1 FY16. CMP Target Price SEPTEMBER 30 th 2015 SYNOPSIS

BUY. IFB AGRO INDUSTRIES LTD Result Update (PARENT BASIS): Q1 FY16. CMP Target Price SEPTEMBER 30 th 2015 SYNOPSIS BUY CMP 382.00 Target Price 440.00 IFB AGRO INDUSTRIES LTD Result Update (PARENT BASIS): Q1 FY16 SEPTEMBER 30 th 2015 ISIN: INE076C01018 Index Details Stock Data Sector Breweries & Distilleries BSE Code

More information

KLRF Ltd. Q3FY11 Result Update. Enhancing investment decisions

KLRF Ltd. Q3FY11 Result Update. Enhancing investment decisions Q3FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis

More information

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials Company Update Automobile February 22, 212 MRF Performance Highlights Y/E Sept. (` cr) 1QSY12 1QSY11 % chg (yoy) 4QSY11 % chg (qoq) Net sales 2,875 2,167 32.7 2,62 9.8 EBITDA 258 243 5.9 181 42.6 EBITDA

More information

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart 5-Jan 5-Apr 5-Jul 5-Oct 5-Jan 5-Apr 5-Jul 5-Oct 5-Jan 5-Apr 5-Jul 5-Oct CCL Products Brewing Steadily CCL Products Limited (CCL) is the largest Indian manufacturer and exporter of instant coffee. With

More information

ITC Ltd. BUY CMP (Rs.) 304 Target (Rs.) 336 Potential Upside(%) 11% Valuation: Investment Rationale. For private circulation only

ITC Ltd. BUY CMP (Rs.) 304 Target (Rs.) 336 Potential Upside(%) 11% Valuation: Investment Rationale. For private circulation only Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18. Volume No.. I Issue No. 186 ITC Ltd September 21, 2018 BSE Code: 500875 NSE Code: ITC Reuters Code: ITC.NS Bloomberg

More information

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart 4QCY2016 Result Update Pharmaceutical March 10, 2017 Sanofi India Performance Highlights Y/E Dec. (` cr) 4QCY2016 3QCY2016 % chg (qoq) 4QCY2015 % chg (yoy) Net sales 552 583 (5.3) 522 5.6 Other income

More information

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%) BUY CMP 55.30 Target Price 65.00 UMANG DAIRIES LTD Result Update (PARENT BASIS): Q4 FY15 JUNE 17 th 2015 ISIN: INE864B01027 Index Details Stock Data Sector Packaged Foods BSE Code 500231 Face Value 5.00

More information

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart. Aug-15 Oct-15 Dec-15 Feb-16 Apr-16 Jun-16 Aug-16 Oct-16 Dec-16 Jan-17 Apr-17 May-17 Jul-17 Sep-17 Nov-17 Jan-18 Mar-18 May-18 Jul-18 1QFY2019 Result Update Cons. Durable August 10, 2018 Blue Star Ltd Performance

More information

Dynamatic Technologies Ltd

Dynamatic Technologies Ltd Q2FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)

More information

Kandagiri Spinning Mills Ltd

Kandagiri Spinning Mills Ltd Q4FY11 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)

More information

Sagar Cements Ltd. Q3FY11 Result Update. Enhancing investment decisions

Sagar Cements Ltd. Q3FY11 Result Update. Enhancing investment decisions Q3FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis

More information

Lakshmi Finance and Industrial Corporation Ltd

Lakshmi Finance and Industrial Corporation Ltd Q1FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)

More information

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months 2QFY217 Result Update Textile November 16, 216 Garware Wall Ropes Performance Highlights Quarterly Data (`cr) 2QFY17 2QFY16 % yoy 1QFY17 % qoq Revenue 232 214 8.5 225 3.3 EBITDA 4 26 5.9 31 29.4 Margin

More information

Company Overview. Financial Performance

Company Overview. Financial Performance Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 CMP: 31.25 December 24, 2015 Stock Details BSE code 523878 BSE ID TOTEX Face value ( ) 10 No of shares (m) 8.1 Market

More information

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics 3QFY2017 Result Update Ceramics January 25, 2017 Asian Granito Performance Highlights Quarterly Data (` cr) 3QFY17 3QFY16 % yoy 2QFY17 % qoq Revenue 247 236 4.3 265 (7.1) EBITDA 34 27 25.3 31 7.2 Margin

More information

GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals 3QFY2017 Result Update Pharmaceutical February 15, 2017 GlaxoSmithKline Pharmaceuticals Performance Highlights Y/E Mar (` cr) 3QFY2017 2QFY2017 % chg (QoQ) 3QFY2016 % chg (YoY) NEUTRAL CMP `2,683 Target

More information

BDH Industries Limited BSE Scrip Code:

BDH Industries Limited BSE Scrip Code: BDH Industries Limited BSE Scrip Code: 524828 Pharmaceuticals October 23, 2012 Equity Statistics Current Market Price Rs. 16.95 52 Week High/Low Rs. 21.00/13.15 Market Capitalisation Rs. Crores 9.76 Free

More information

APOLLO TYRES LTD. October 19 th, CMP (Rs.) 194. Key Developments

APOLLO TYRES LTD. October 19 th, CMP (Rs.) 194. Key Developments Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 s. APOLLO TYRES LTD.. October 19 th, 2015 BSE Code: 500877 NSE Code: APOLLOTYRE Reuters Code: APLO.NS Bloomberg

More information

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months Jan-12 Jun-12 Nov-12 Apr-13 Sep-13 Feb-14 Jul-14 Dec-14 May-15 Oct-15 Mar-16 Aug-16 Jan-17 Jun-17 Nov-17 2QFY2018 Result Update Agrichemical November 21, 2017 Rallis India Performance Highlights Y/E March

More information

Siyaram Silk Mills Ltd

Siyaram Silk Mills Ltd Q4FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis

More information

Symphony Ltd. RESULT UPDATE 31st October 2017

Symphony Ltd. RESULT UPDATE 31st October 2017 . RESULT UPDATE 31st October 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update Q2FY18 II 31st October 2017. CMP INR 1,465 Target INR 1,700 Potential

More information

Religare Investment Call

Religare Investment Call Q3FY18 Result Update Auto Ancillary BUY CMP (Rs) Target Price (Rs) Potential Upside Sensex Nifty Key Stock data BSE Code NSE Code Bloomberg Shares o/s, Cr (FV 10) Market Cap (Rs Cr) 3M Avg Volume 52 week

More information

Shri Lakshmi Cotsyn Ltd

Shri Lakshmi Cotsyn Ltd Q3FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis

More information

Religare Investment Call

Religare Investment Call v-17 v-17 Dec-17 Jan-18 Jan-18 Feb-18 Mar-18 Mar-18 Apr-18 May-18 May-18 Jun-18 Jul-18 Aug-18 Aug-18 Sep-18 Oct-18 Oct-18 Q2FY19 Result Update Q2FY19 Result Update BUY CMP (Rs) 282 Target Price (Rs) 321

More information

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212 2QCY17 Result Update July 20, 2017 Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212 Well-placed in Power T&D Hi-tech Space; Order Book Remains Robust India s revenue rose by 6.0% YoY to Rs23.3bn

More information

Nestlé India. Q4CY16 Result Update. Healthy Sales growth; higher provisions & CSR impacts bottom-line. Sector: FMCG CMP: ` 6,169. Recommendation: BUY

Nestlé India. Q4CY16 Result Update. Healthy Sales growth; higher provisions & CSR impacts bottom-line. Sector: FMCG CMP: ` 6,169. Recommendation: BUY Nestlé India Q4CY16 Result Update Healthy Sales growth; higher provisions & CSR impacts bottom-line Sector: FMCG CMP: ` 6,169 Recommendation: BUY Market statistics Current stock price (`) 6,169 Shares

More information

PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD Result Update (PARENT BASIS): Q4 FY15

PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD Result Update (PARENT BASIS): Q4 FY15 PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD Result Update (PARENT BASIS): Q4 FY15 ISIN: INE179A01014 OCTOBER 5 th 2015 STOCK DETAILS Sector FMCG BSE Code 500459 Face Value 10.00 52wk. High / Low (Rs.) 7435.00/5144.40

More information

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart Jul-15 Sep-15 Nov-15 Jan-16 Mar-16 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 Jul-17 Sep-17 Nov-17 Jan-18 Mar-18 May-18 1QFY2019 Result Update Automobile July 27, 2018 Maruti Suzuki India Performance

More information

KLRF Ltd. Q2FY11 Result Update. Enhancing investment decisions

KLRF Ltd. Q2FY11 Result Update. Enhancing investment decisions Q2FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis

More information

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period - 2QFY2013 Result Update Oil & Gas October 26, 2012 GAIL India Performance Highlights Quarterly highlights (Standalone) Y/E March (` cr) 2QFY2013 2QFY2012 % chg (yoy) 1QFY2013 % chg (qoq) Net sales 11,361

More information

Nestlé India. Q2CY17 Result Update. Positives priced in; Downgrade to Hold. Sector: FMCG CMP: ` 6,786. Recommendation: HOLD

Nestlé India. Q2CY17 Result Update. Positives priced in; Downgrade to Hold. Sector: FMCG CMP: ` 6,786. Recommendation: HOLD Nestlé India Q2CY17 Result Update Positives priced in; Downgrade to Hold Sector: FMCG CMP: ` 6,786 Recommendation: HOLD Market statistics Current stock price (`) 6,786 Shares O/S (cr.) 9.6 Mcap (`cr) 65,424

More information

Fineotex Chemical Ltd

Fineotex Chemical Ltd Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to

More information

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart. Feb-15 May-15 Aug-15 Oct-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 3QFY2018 Result Update Coffee February 5, 2018 CCL Products Performance Update Y/E March (` cr) Q3FY18 Q3FY17

More information

BUY. MENON PISTONS LTD Result Update (PARENT BASIS): Q1 FY16 SYNOPSIS. CMP Target Price SEPTEMBER 3 rd, 2015

BUY. MENON PISTONS LTD Result Update (PARENT BASIS): Q1 FY16 SYNOPSIS. CMP Target Price SEPTEMBER 3 rd, 2015 BUY CMP 151.00 Target Price 174.00 MENON PISTONS LTD Result Update (PARENT BASIS): Q1 FY16 SEPTEMBER 3 rd, 2015 ISIN: INE650G01011 Stock Details Stock Data Sector Auto Parts & Equipment BSE Code 531727

More information

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months 3QFY2017 Result Update FMCG January 30, 2017 ITC Performance Highlights Quarterly result (Standalone) (` cr) 3QFY17 3QFY16 % yoy 2QFY17 %qoq Revenue 9,248 8,867 4.3 9,661 (4.3) EBITDA 3,546 3,475 2.1 3,630

More information

Apollo Hospitals Enterprise Ltd.

Apollo Hospitals Enterprise Ltd. Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17. Volume No.. I Issue No. 154 Apollo Hospitals Enterprise Ltd. December 19, 2017 BSE Code: 508869 NSE Code: APOLLOHOSP

More information

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period - 4QCY2012 Result Update Cement February 11, 2013 ACC Performance Highlights Quarterly results (Standalone) Y/E Dec. (` cr) 4QCY2012 3QCY2012 % chg qoq 4QCY2011 % chg yoy Net sales 3,099 2,445 26.8 2,503

More information

Larsen & Toubro Ltd.

Larsen & Toubro Ltd. Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Volume No.. III Issue No. 163. Larsen & Toubro Ltd. February 26, 2018 BSE Code: 500510 NSE Code: LT Reuters Code:

More information

Religare Investment Call

Religare Investment Call BUY CMP (Rs) Target Price (Rs) Potential Upside Sensex Nifty Key Stock data BSE Code NSE Code Bloomberg Shares o/s, Cr (FV 1) Market Cap (Rs Cr) 3M Avg Volume 52 week H/L Shareholding Pattern (%) Dec-16

More information

BUY. KDDL LTD Result Update (PARENT BASIS): Q1 FY16 SYNOPSIS. CMP Target Price AUGUST 22 nd 2015 ISIN: INE291D01011

BUY. KDDL LTD Result Update (PARENT BASIS): Q1 FY16 SYNOPSIS. CMP Target Price AUGUST 22 nd 2015 ISIN: INE291D01011 BUY CMP 280.10 Target Price 322.00 KDDL LTD Result Update (PARENT BASIS): Q1 FY16 AUGUST 22 nd 2015 ISIN: INE291D01011 Index Details Stock Data Sector Other Apparels & Accessories BSE Code 532054 Face

More information

Company Overview. Financial Performance

Company Overview. Financial Performance Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Anisha Impex Ltd CMP: 11.85 December 31, 2015 Stock Details BSE code 537785 BSE ID Face value ( ) 10 No of shares (m)

More information

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods 1QFY2012 Result Update Capital Goods July 25, 2011 Graphite India Performance Highlights Y/E March (` cr) 1QFY2012 4QFY2011 % chg (qoq) 1QFY2011 % chg (yoy) Net sales 319 303 5.1 258 23.3 EBITDA 61 59

More information

BUY SIMPLEX INFRASTRUCTURES LTD SYNOPSIS. CMP Target Price FEBRUARY 28 th Result Update (PARENT BASIS): Q3 FY15

BUY SIMPLEX INFRASTRUCTURES LTD SYNOPSIS. CMP Target Price FEBRUARY 28 th Result Update (PARENT BASIS): Q3 FY15 BUY CMP 408.40 Target Price 460.00 SIMPLEX INFRASTRUCTURES LIMITED Result Update (PARENT BASIS): Q3 FY15 FEBRUARY 28 th 2015 ISIN: INE059B01024 Index Details Stock Data Sector Construction & Engineering

More information

The West Coast Paper Mills Ltd

The West Coast Paper Mills Ltd Q4FY11 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)

More information

Religare Investment Call

Religare Investment Call BUY CMP (Rs) Target Price (Rs) Potential Upside Sensex Nifty Key Stock data BSE Code NSE Code Bloomberg Shares o/s, Cr (FV 2) Market Cap (Rs Cr) 3M Avg Volume 52 week H/L Shareholding Pattern (%) Promoter

More information

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months 2QFY2019 Result Update Dairy Products November 6, 2018 Parag Milk Foods Performance Update Y/E March (` cr) Q2FY19 Q2FY18 % yoy Q1FY19 % qoq Net sales 573 505 13.7% 549 4.4% EBITDA 58 50 16.3% 60-2.7%

More information

Hydro S&S Industries Ltd

Hydro S&S Industries Ltd Q3FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis

More information

Nestle India Ltd. RESULT UPDATE

Nestle India Ltd. RESULT UPDATE RESULT UPDATE 15th May 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update Q1CY17 II 15th May, 2017 CMP INR 6819 Target INR 7075 Potential Upside

More information

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months 1QFY2019 Result Update Dairy Products August 8, 2018 Parag Milk Foods Performance Update Y/E March (` cr) Q1FY19 Q1FY18 % yoy Q4FY18 % qoq Net sales 549 413 32.9 518 5.9 EBITDA 60 29 103% 55 8.4% EBITDA

More information

Wendt (India) Ltd. Q1FY12 Result Update. Enhancing investment decisions. CRISIL Limited. All Rights Reserved.

Wendt (India) Ltd. Q1FY12 Result Update. Enhancing investment decisions. CRISIL Limited. All Rights Reserved. Q1FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)

More information

ABB LTD (INDIA) RESEARCH

ABB LTD (INDIA) RESEARCH RESULTS REVIEW Share Data Market Cap Rs. 168.6 bn Price Rs. 795.80 BSE Sensex 16,741.30 Reuters Bloomberg Avg. Volume (52 Week) ABB.BO ABB IN 0.11 mn 52-Week High/Low Rs. 856.95 / 344 Shares Outstanding

More information

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart. May- Aug- Oct-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 4QFY2018 Result Update Cable May 21, 2018 KEI Industries Performance Update Y/E March (` cr) 4QFY18 4QFY17 % yoy 3QFY18

More information

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials 3QFY2018 Result Update Cable January 25, 2018 KEI Industries Performance Update Y/E March (` cr) 3QFY18 3QFY17 % yoy 2QFY18 % qoq Net sales 889 715 24 749 19 EBITDA 84 77 10 76 11 EBITDA margin (%) 9.5

More information

Religare Investment Call

Religare Investment Call Q2FY18 Result Update Auto Ancillary BUY CMP (Rs) Target Price (Rs) Potential Upside Sensex Nifty 144 173 % 33,219 10,303 Operational efficiency to continue ' Revenue (growth not comparable due to change

More information

Nestlé India Outlook Hazy; Valuations Prohibitive

Nestlé India Outlook Hazy; Valuations Prohibitive Nestlé India Outlook Hazy; Valuations Prohibitive Nestlé India s net sales, EBITDA and net profit surged by 35% yoy, 67% yoy & 116% yoy to Rs23.5bn, Rs4.5bn & Rs2.7bn, respectively in 3QCY16. This growth

More information

The Varhad Group. Prag Bosimi Synthetics Ltd. Company Overview. FY15 and recent performance CMP: INR5.56. Stock data. Stock performance (%)

The Varhad Group. Prag Bosimi Synthetics Ltd. Company Overview. FY15 and recent performance CMP: INR5.56. Stock data. Stock performance (%) Textiles l BSE Research Prag Bosimi Synthetics Ltd. CMP: INR5.56 Stock data BSE code 500192 BSE ID PRAGBOS Face value (INR) 10.0 No of shares (m) 74.4 Market cap (INRm) 413.6 3m avg. daily vol (No) 2,491.6

More information

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy 4QFY16 Result Update Institutional Equities Timken India 23 May 2016 Reuters: TMKN.BO; Bloomberg: TIMK IN Margin Expansion Leads To Huge Growth In Profit; Retain Buy Timken India (TIL), the leading manufacturer

More information

Visaka Industries Ltd

Visaka Industries Ltd Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%

More information

HOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017

HOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017 2QCY17 Result Update July 27,2017 Market Cap. (Rs bn) 657 Free Float (%) 37.3 Shares O/S (mn) 96 Good Performance Irrespective of GST Pangs Nestlé India has reported a good set of numbers for 2QCY17 in

More information

Bharat Forge. Result Update. Q4FY13 Result Highlights. Valuation. No Respite in Sight May 29, Institutional Research 1

Bharat Forge. Result Update. Q4FY13 Result Highlights. Valuation. No Respite in Sight May 29, Institutional Research 1 [ Result Update Equity India Forging & Industrials Bharat Forge Ltd. No Respite in Sight May 29, 2013 CMP (`) Target (`) 241 238 Potential Upside Absolute Rating (1.24)% HOLD Market Info (as on May 28,

More information

Mahindra & Mahindra Ltd.

Mahindra & Mahindra Ltd. May-15 Aug-15 Nov-15 Feb-16 May-16 Aug-16 Nov-16 Feb-17 May-17 Aug-17 Nov-17 Feb-18 4QFY2018 Result Update Automobile May 30, 2018 Mahindra & Mahindra Ltd. Performance Update Y/E March (` cr) 4QFY18 4QFY17

More information

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart. May-15 Aug-15 Nov-15 Feb-16 May-16 Aug-16 Nov-16 Feb-17 May-17 Aug-17 Nov-17 Feb-18 May-18 4QFY2018 Result Update Cons. Durable May 16, 2018 Blue Star Ltd Performance Update 4QFY18 4QFY17 % chg. (yoy)

More information

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart Oct-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Jul-18 Oct-18 2QFY2019 Result Update Automobile November 3, 2018 Maruti Suzuki India Performance Update Y/E March (` cr) 2QFY19

More information

Bloomberg Code: ATA IN

Bloomberg Code: ATA IN Auto OEM: 3-Wheelers Atul Feb Auto 03, 2015 Ltd India Research Stock Broking Bloomberg Code: ATA IN Stable quarter led by surge in exports volumes (TP revised ) : Operating revenue, EBITDA and PAT grew

More information

Maruti Suzuki (RHS) BUY. Operationally In Line; Reiterate Buy. Automobiles October 31, 2014 RESULT REVIEW. Outlook & Valuation.

Maruti Suzuki (RHS) BUY. Operationally In Line; Reiterate Buy. Automobiles October 31, 2014 RESULT REVIEW. Outlook & Valuation. Oct13 Dec13 Jan14 Feb14 Apr14 May14 Jun14 Aug14 Sep14 Oct14 India Research Automobiles RESULT REVIEW Bloomberg: MSIL IN Reuters: MRTI.BO BUY Operationally In Line; Reiterate Buy India s (MSIL) Revenue/EBIDTA/PAT

More information

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart. Initiating Coverage Plywood March 03, 2018 Greenply Industries The plywood maker for growing India Greenply Industries Ltd (GIL) manufactures plywood & allied products and medium density fibreboards (MDF).

More information

Savera Industries Ltd

Savera Industries Ltd Q2FY12 Result Update Enhancing investment decisions CRISIL Limited. All Rights Reserved. Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix)

More information

Lakshmi Finance and Industrial Corporation Ltd

Lakshmi Finance and Industrial Corporation Ltd Q2FY11 Result Update Enhancing investment decisions Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis

More information

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart Jan-12 Jul-12 Jan-13 Jul-13 Jan-14 Jul-14 Jan-15 Jul-15 Jan-16 Jul-16 Jan-17 1QFY2018 Result Update Agrichemical July 26, 2017 Rallis India Performance Highlights Y/E March (` cr) 1QFY2018 4QFY2017 % chg

More information

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months 2QFY2019 Result Update Industrial Machinery October 26, 2018 GMM Pfaudler Limited Performance Update Standalone (` cr) Q2FY19 Q2FY18 % yoy Q1FY19 % qoq Net sales 99.2 93.2 29.8% 76.4 6.4% EBITDA 16.0 15.3

More information

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart. 4QFY2018 Result Update Cable May 7, 2018 Matrimony.com Ltd Performance Update Y/E March (` cr) 4QFY18 4QFY17 % yoy 3QFY18 % qoq Net sales 84 75 12 84 1 EBITDA 20 11 78 17 15 EBITDA margin (%) 23.6 14.8

More information